RaQualia Pharma Inc.

4579・Growth Market・Pharmaceuticals

Official website

RaQualia Pharma Inc.

4579・Growth Market・Pharmaceuticals

Official website

RaQualia Pharma Inc.4579

Reference Indicators

Market Cap

120¥100M

P/E (Forecast)

—

P/B

1.7x

Dividend Yield (Forecast)

0.00%

ROE

4.4%

EV/EBITDA

11.8x

Financial Summary

Unit: ¥M

Item	2021Dec 2021	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025
Net Sales	2,776	2,918	1,901	3,107	3,979
Operating Income	707	866	-337	-213	483
Non-operating Income	177	76	88	67	69
Non-operating Expenses	21	38	44	215	115
Ordinary Income	863	904	-293	-361	437
Extraordinary Income	16	14	—	9	—
Extraordinary Losses	—	67	0	5	—
Pre-tax Income	880	851	-294	-357	437
Income Taxes	124	127	29	137	164
Net Income	755	723	-323	-495	273
EBITDA	849	1,013	-161	188	971
Operating Margin	25.5%	29.7%	-17.7%	-6.9%	12.2%
ROA	14.4%	11.6%	-4.7%	-5.1%	2.6%
ROE	17.2%	14.1%	-5.4%	-8.9%	4.4%